Successful alternate day guanidine therapy following guanidine-induced neutropenia in the Lambert-Eaton myasthenic syndrome.
作者信息
Silbert P L, Hankey G J, Barr A L
出版信息
Muscle Nerve. 1990 Apr;13(4):360-1. doi: 10.1002/mus.880130413.
PMID:2355949
Abstract
摘要
相似文献
1
Successful alternate day guanidine therapy following guanidine-induced neutropenia in the Lambert-Eaton myasthenic syndrome.在兰伯特-伊顿肌无力综合征中，胍诱导的中性粒细胞减少症后成功进行隔日胍治疗。
Muscle Nerve. 1990 Apr;13(4):360-1. doi: 10.1002/mus.880130413.
2
[Lambert-Eaton myasthenic syndrome].
Nihon Rinsho. 1990 Jul;48(7):1477-82.
3
Therapeutic approaches to Lambert-Eaton myasthenic syndrome in the intra-individual comparison.个体内比较中兰伯特-伊顿肌无力综合征的治疗方法
Wien Klin Wochenschr. 1991;103(20):629-32.
4
Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome.低剂量胍和吡啶斯的明：兰伯特-伊顿肌无力综合征相对安全有效的长期对症治疗方法。
Muscle Nerve. 1997 Sep;20(9):1146-52. doi: 10.1002/(sici)1097-4598(199709)20:9<1146::aid-mus9>3.0.co;2-8.
5
Current therapy of the Lambert-Eaton myasthenic syndrome.兰伯特-伊顿肌无力综合征的当前治疗方法。
Prog Brain Res. 1990;84:163-70. doi: 10.1016/s0079-6123(08)60900-0.
6
[Cyclosporin A in the treatment of Eaton-Lambert myasthenic syndrome].[环孢素A治疗伊顿-兰伯特肌无力综合征]
An Med Interna. 1996 Jan;13(1):25-6.
7
Lambert-Eaton myasthenic syndrome: evaluation of movement performance following drug therapy.兰伯特-伊顿肌无力综合征：药物治疗后运动表现评估
Electromyogr Clin Neurophysiol. 1994 Mar;34(2):87-93.
8
[The treatment of the Eaton-Lambert myasthenic syndrome with 3,4-diaminopyridine].
Rev Clin Esp. 1993 Apr;192(7):354-5.
9
[The drug treatment of the Lambert-Eaton myasthenic syndrome].[兰伯特-伊顿肌无力综合征的药物治疗]
Eksp Klin Farmakol. 1999 Nov-Dec;62(6):69-71.
10
Guanidine and germine in Eaton-Lambert syndrome.伊顿-兰伯特综合征中的胍和胚芽碱。
Neurology. 1976 Oct;26(10):944-6. doi: 10.1212/wnl.26.10.944.
Zotero 插件